PFM has been carefully managing and adapting to the outbreak of coronavirus (COVID-19). We are currently working to ensure the health of our people, our clients and our larger community. This includes policies on meetings, events and travel that evolve as circumstances change.
Following provincial guidelines, as of March 23, 2020, our office will be closed to the public. Please continue to remit payments and/or submit invoices in the usual manner.
The office will remain closed to the public until further notice. In the interim, if you need to get in contact, please call the office at 306-791-4855.
PFM Recent Exit – CanniMed Therapeutics Inc.
March 15th, 2018
CanniMed Therapeutics Inc. – Exit
CanniMed Therapeutics (“CanniMed”) is a licensed producer of medical grade cannabis based in Saskatoon, Saskatchewan. PFM’s first investment into CanniMed was in 2012 through an equity raise used to finance the expansion of the Company’s production facilities. Over the next 5 years, PFM continued to support the Company through additional investments for a total investment of $9.7 million. In January, the Company agreed to accept a takeover offer from Aurora Cannabis Inc. in a cash & share transaction valued at $1.1 billion. In March, PFM received its portion of Aurora shares and subsequently sold them through the public market.
Through its affiliation with the fund managers PFM Fund Operations, PFM Venture Capital, Prairie Ventures GP, TopSoil Farm Land Management, and TopSoil Farm Land Management (II), and doing business as PFM Capital ("PFM Capital" or "PFM"), PFM is a leading private equity investment firm in Saskatchewan. Founded in 1989 as a corporate finance company, PFM has been managing private equity and venture capital funds since 1993. This website does not represent an offering of securities. The information disclosed is incomplete and can be qualified in its entirety by each fund's most recent offering document or limited partnership agreement, obtainable free of charge by contacting PFM Capital Inc. The securities described herein are only available to eligible investors in Canada in accordance with applicable securities laws.